Norbert Pardi

Norbert Pardi

University of Pennsylvania

H-index: 40

North America-United States

About Norbert Pardi

Norbert Pardi, With an exceptional h-index of 40 and a recent h-index of 40 (since 2020), a distinguished researcher at University of Pennsylvania, specializes in the field of mRNA therapeutics, vaccines.

His recent articles reflect a diverse array of research interests and contributions to the field:

Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction

mRNA-LNP vaccine-induced CD8+ T-cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies.

Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination

Enhancing prime editor activity by directed protein evolution in yeast

Single cell phototransfection of mRNAs encoding SARS-CoV2 spike and nucleocapsid into human astrocytes results in RNA dependent translation interference

Expression and purification of the receptor‐binding domain of SARS‐CoV‐2 spike protein in mammalian cells for immunological assays

Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth

mRNA vaccination of rabbits alters the fecundity, but not the attachment, of adult Ixodes scapularis

Norbert Pardi Information

University

Position

___

Citations(all)

11176

Citations(since 2020)

10535

Cited By

2649

hIndex(all)

40

hIndex(since 2020)

40

i10Index(all)

68

i10Index(since 2020)

65

Email

University Profile Page

Google Scholar

Norbert Pardi Skills & Research Interests

mRNA therapeutics

vaccines

Top articles of Norbert Pardi

Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction

Cell Host & Microbe

2024/4/25

mRNA-LNP vaccine-induced CD8+ T-cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies.

Molecular Therapy

2024/4/11

Norbert Pardi
Norbert Pardi

H-Index: 19

Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination

Nature Immunology

2024/3/14

Enhancing prime editor activity by directed protein evolution in yeast

Nature Communications

2024/3/7

Single cell phototransfection of mRNAs encoding SARS-CoV2 spike and nucleocapsid into human astrocytes results in RNA dependent translation interference

Frontiers in Drug Delivery

2024/3/5

Expression and purification of the receptor‐binding domain of SARS‐CoV‐2 spike protein in mammalian cells for immunological assays

FEBS Open bio

2024/3

Norbert Pardi
Norbert Pardi

H-Index: 19

Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth

npj Vaccines

2024/2/20

Richard Barfield
Richard Barfield

H-Index: 10

Norbert Pardi
Norbert Pardi

H-Index: 19

mRNA vaccination of rabbits alters the fecundity, but not the attachment, of adult Ixodes scapularis

Scientific Reports

2024/1/4

Yingjun Cui
Yingjun Cui

H-Index: 8

Norbert Pardi
Norbert Pardi

H-Index: 19

Mosaic sarbecovirus vaccination elicits cross-reactive responses in pre-immunized animals (preprint)

bioRxiv

2024

Author Correction: A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax

npj Vaccines

2024

Treatment of a genetic liver disease in mice through transient prime editor expression

bioRxiv

2024

Transient growth factor expression via mRNA in lipid nanoparticles promotes hepatocyte cell therapy to treat murine liver diseases

bioRxiv

2024

Fatima Rizvi
Fatima Rizvi

H-Index: 6

Norbert Pardi
Norbert Pardi

H-Index: 19

VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis

Cell Stem Cell

2023/12/7

Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer

Science Advances

2023/1/27

Cryptic MHC-E epitope from influenza elicits a potent cytolytic T cell response

Nature Immunology

2023/11

Nucleoside modified mrna and uses thereof

2023/10/26

Nucleoside‐modified mRNA vaccines yield robust blocking antibody responses against major house dust mite allergens

Allergy

2023/1/1

Norbert Pardi
Norbert Pardi

H-Index: 19

Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability

npj Vaccines

2023/10/11

Hao Li
Hao Li

H-Index: 5

Norbert Pardi
Norbert Pardi

H-Index: 19

DELAYED INTRASPINAL DELIVERY OF MRNAS ENCODING A COMBINATION OF CYTOKINES AND GDNF PROMOTES MORPHOLOGICAL AND FUNCTIONAL RECOVERY FOLLOWING SPINAL CORD INJURY

IBRO Neuroscience Reports

2023/10/1

Development of an mRNA-lipid nanoparticle vaccine against Lyme disease

Molecular Therapy

2023/9/6

See List of Professors in Norbert Pardi University(University of Pennsylvania)